Liu Dongfang 4
4 · Nuvation Bio Inc. · Filed Dec 3, 2025
Insider Transaction Report
Form 4
Liu Dongfang
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Class A Common Stock
2025-12-01$2.93/sh+150,000$439,500→ 168,000 total - Sale
Class A Common Stock
2025-12-01$7.82/sh−150,000$1,173,255→ 18,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-01−150,000→ 165,000 totalExercise: $2.93Exp: 2032-08-28→ Class A Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.80 to $7.855. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Option vested as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date